Lord, Abbett & Co
ANAC

Lord, Abbett & Co’s ANACOR PHARMACEUTICALS INC COM ANAC Stock Holding History

Lord, Abbett & Co’s Portfolio ANAC Stock Details ANAC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-131,698
Closed -$14.9M – 1022
2015
Q4 		$14.9M Sell
131,698
-67,566
-34% -$7.44M 0.04% 508
2015
Q3 		$23.5M Buy
199,264
+65,613
+49% +$8.57M 0.07% 380
2015
Q2 		$10.3M Sell
133,651
-81,081
-38% -$5.32M 0.03% 635
2015
Q1 		$12.4M Buy
214,732
+105,080
+96% +$4.46M 0.03% 579
2014
Q4 		$3.54M Buy
+109,652
New +$3.29M 0.01% 788

Other funds holding ANAC

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

Lord, Abbett & Co's ANAC Position: Q1 2016 in Review

Lord, Abbett & Co sold out of ANACOR PHARMACEUTICALS INC COM (ANAC) in Q1 2016, closing a stake of 131,698 shares — an estimated $14.9M sold.

Lord, Abbett & Co first reported a position in ANAC in Q4 2014 and held it in 5 quarters. The position peaked at $23.5M in Q3 2015. 199 funds tracked by Wall St. Rank hold ANAC as of Q1 2016.

  • Lord, Abbett & Co reported no remaining ANACOR PHARMACEUTICALS INC COM position as of Q1 2016 after selling out during the quarter.
  • Lord, Abbett & Co sold 131,698 ANACOR PHARMACEUTICALS INC COM shares in Q1 2016, an estimated $14.9M.
  • Lord, Abbett & Co first reported a position in ANACOR PHARMACEUTICALS INC COM in Q4 2014 and held it in 5 quarters.
  • Lord, Abbett & Co's ANACOR PHARMACEUTICALS INC COM position peaked at $23.5M in Q3 2015.
  • 199 funds tracked by Wall St. Rank held ANACOR PHARMACEUTICALS INC COM as of Q1 2016.

Based on Lord, Abbett & Co's 13F filing for Q1 2016, filed 16 May 2016.